A potent antimetastatic activity was also reported by treating PCa cells with GnRH antagonists, further supporting the notion that these compounds behave as agonists at the level of the GnRH-R expressed in cancer cells. The gene discussed is GNRH1; the disease is posterior cortical atrophy.